AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 26-50/131
AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION VERSUS AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ADULTS AND CHILDREN WITH NONLEUKEMIC MALIGNANT DISEASE - A RANDOMIZED ECONOMIC-STUDY
Authors: LECORROLLER AG FAUCHER C AUPERIN A BLAISE D FORTANIER C BENHAMOU E HARTMANN O BROSSE JC MARANINCHI D MOATTI JP
Citation: Ag. Lecorroller et al., AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION VERSUS AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ADULTS AND CHILDREN WITH NONLEUKEMIC MALIGNANT DISEASE - A RANDOMIZED ECONOMIC-STUDY, PharmacoEconomics, 11(5), 1997, pp. 454-463
CLINICAL AND BIOLOGICAL EFFECTS OF GAMMA-INTERFERON AND THE COMBINATION OF GAMMA-INTERFERON AND INTERLEUKIN-2 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: VEY N VIENS P FOSSAT C OLIVE D SAINTY D BAUME D STOPPA AM BOUABDALLAH R BRANDELY M GASTAUT JA MARANINCHI D BLAISE D
Citation: N. Vey et al., CLINICAL AND BIOLOGICAL EFFECTS OF GAMMA-INTERFERON AND THE COMBINATION OF GAMMA-INTERFERON AND INTERLEUKIN-2 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION, European cytokine network, 8(4), 1997, pp. 389-394
THE USE OF A SEQUENTIAL HIGH-DOSE RECOMBINANT INTERLEUKIN-2 REGIMEN AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION DOES NOT IMPROVE THE DISEASE-FREE SURVIVAL OF PATIENTS WITH ACUTE-LEUKEMIA TRANSPLANTED IN FIRSTCOMPLETE REMISSION
Authors: BLAISE D ATTAL M PICO JL REIFFERS J STOPPA AM BELLANGER C MOLINA L NEDELLEC G VERNANT JP LEGROS M GABUS R HUGUET F BRANDELY M HERCEND T OLIVE D MARANINCHI D
Citation: D. Blaise et al., THE USE OF A SEQUENTIAL HIGH-DOSE RECOMBINANT INTERLEUKIN-2 REGIMEN AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION DOES NOT IMPROVE THE DISEASE-FREE SURVIVAL OF PATIENTS WITH ACUTE-LEUKEMIA TRANSPLANTED IN FIRSTCOMPLETE REMISSION, Leukemia & lymphoma, 25(5-6), 1997, pp. 469-478
OPTIMIZATION OF PERIPHERAL-BLOOD STEM-CELL COLLECTION (PBSC) BY LEUKAPHERESIS - A CASE OF INTERACTION BETWEEN ECONOMIC AND CLINICAL-ASSESSMENT OF AN INNOVATION
Authors: LECORROLLER AG MOATTI JP CHABANNON C FAUCHER C BLAISE D FORTANIER D LADAIQUE P BLACHE BL NOVAKOVITCH G MARANINCHI D
Citation: Ag. Lecorroller et al., OPTIMIZATION OF PERIPHERAL-BLOOD STEM-CELL COLLECTION (PBSC) BY LEUKAPHERESIS - A CASE OF INTERACTION BETWEEN ECONOMIC AND CLINICAL-ASSESSMENT OF AN INNOVATION, European journal of cancer, 33, 1997, pp. 18-18
AN EARLY ECONOMIC-EVALUATION OF A THERAPEUTIC INNOVATION IN THE FIELDOF CANCEROLOGY - THE CASE OF THE PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) ALLOGENEIC TRANSPLANTATION
Authors: FORTANIER C FAUCHER C TONNAIRE G PROTIERE C LECOROLLIER AG BLAISE D MOATTI JP
Citation: C. Fortanier et al., AN EARLY ECONOMIC-EVALUATION OF A THERAPEUTIC INNOVATION IN THE FIELDOF CANCEROLOGY - THE CASE OF THE PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) ALLOGENEIC TRANSPLANTATION, European journal of cancer, 33, 1997, pp. 23-23
GENE MARKING OF HUMAN STEM-CELLS DERIVED FROM PERIPHERAL-BLOOD AND FETAL LIVER - FROM THE PRECLINICAL TESTS TO THE CLINICAL-TRIAL
Authors: BAGNIS C HUMEAU L IMBERT AM CHABANNON C NAMIKAWA R BLAISE D MANNONI P
Citation: C. Bagnis et al., GENE MARKING OF HUMAN STEM-CELLS DERIVED FROM PERIPHERAL-BLOOD AND FETAL LIVER - FROM THE PRECLINICAL TESTS TO THE CLINICAL-TRIAL, Cancer gene therapy, 4(6), 1997, pp. 82-82
TAGGING AND TRACKING OF PERIPHERAL-BLOOD CD34- FROM THE LABORATORY BENCH TO THE PATIENT( CELLS RETROVIRALLY TRANSDUCED WITH A NLSLACZ MARKER GENE )
Authors: BAGNIS C HUMEAU L IMBERT AM BLAISE D MANNONI P
Citation: C. Bagnis et al., TAGGING AND TRACKING OF PERIPHERAL-BLOOD CD34- FROM THE LABORATORY BENCH TO THE PATIENT( CELLS RETROVIRALLY TRANSDUCED WITH A NLSLACZ MARKER GENE ), Cancer gene therapy, 4(5), 1997, pp. 323-323
INTENSIVE SEQUENTIAL CHEMOTHERAPY WITH REPEATED BLOOD STEM-CELL SUPPORT FOR UNTREATED POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA
Authors: STOPPA AM BOUABDALLAH R CHABANNON C NOVAKOVITCH G VEY N CAMERLO J BLAISE D XERRI L RESBEUT M DISTEFANO D BARDOU VJ GASTAUT JA MARANINCHI D
Citation: Am. Stoppa et al., INTENSIVE SEQUENTIAL CHEMOTHERAPY WITH REPEATED BLOOD STEM-CELL SUPPORT FOR UNTREATED POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 15(5), 1997, pp. 1722-1729
AUTOLOGOUS VERSUS ALLOGENEIC STEM-CELL TRANSPLANTATION IN ADULTS WITHACUTE MYELOID-LEUKEMIA (AML) IN FIRST REMISSION (BGMT-91 PROTOCOL)
Authors: REIFFERS J STOPPA AM HUGUET F MOLINA L MARIT G BLAISE D ATTAL K ROSSI JF SOTTO JJ FABERES C
Citation: J. Reiffers et al., AUTOLOGOUS VERSUS ALLOGENEIC STEM-CELL TRANSPLANTATION IN ADULTS WITHACUTE MYELOID-LEUKEMIA (AML) IN FIRST REMISSION (BGMT-91 PROTOCOL), Experimental hematology, 25(8), 1997, pp. 206-206
A PILOT-STUDY TO EVALUATE THE FEASIBILITY OF USING EXPANDED MARROW-CELLS AND PROGENITORS TO SUPPORT SEQUENTIAL HIGH-DOSES OF ALKYLATING-AGENTS IN PATIENTS WITH ADVANCED BREAST-CANCER
Authors: CHABANNON C SIELLEUR I DOUVILLE J BLACHE JL FAUCHER C TONNAIRE G NOVAKOVITCH G APPEL M FISH R GRAVIS G BERTUCCI F STOPPA AM BLAISE D CHABBERT I MOATTI JP MULLER T OGIER W ARMSTRONG D MARANINCHI D VIENS P
Citation: C. Chabannon et al., A PILOT-STUDY TO EVALUATE THE FEASIBILITY OF USING EXPANDED MARROW-CELLS AND PROGENITORS TO SUPPORT SEQUENTIAL HIGH-DOSES OF ALKYLATING-AGENTS IN PATIENTS WITH ADVANCED BREAST-CANCER, Experimental hematology, 25(8), 1997, pp. 277-277
LENOGRASTIM AS A PRIMING AGENT FOR ALLOGENEIC STEM-CELL TRANSPLANTATION
Authors: BLAISE D JOURDAN E FEGUEUX N MICHALLET M REIFFERS J JOUET JP MICHEL G FAUCHER C FORTANIER C HUA A SCHULLER MP BADRI N CHABANNON C MARANINCHI D
Citation: D. Blaise et al., LENOGRASTIM AS A PRIMING AGENT FOR ALLOGENEIC STEM-CELL TRANSPLANTATION, Experimental hematology, 25(8), 1997, pp. 325-325
INTENSIVE SEQUENTIAL CHEMOTHERAPY (ISC92-95) AND REPEATED PERIPHERAL-BLOOD STEM-CELL (PBSC) IN POOR-RISK UNTREATED NON-HODKIN-LYMPHOMA (NHL)
Authors: STOPPA AM BOUABDALLAH R CHABANNON C VEY N ROSSI JF BOULAT O COSTELLO R CAMERLO J NOVAKOVITCH G BARDOU VJ BLAISE D GASTAUT JA MARANINCHI D
Citation: Am. Stoppa et al., INTENSIVE SEQUENTIAL CHEMOTHERAPY (ISC92-95) AND REPEATED PERIPHERAL-BLOOD STEM-CELL (PBSC) IN POOR-RISK UNTREATED NON-HODKIN-LYMPHOMA (NHL), Experimental hematology, 25(8), 1997, pp. 410-410
TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH HIGH-DOSE RECOMBINANT INTERLEUKIN-2 - RESULTS OF A PHASE-II STUDY IN 21 PATIENTS
Authors: VEY N BLAISE D OLIVE D LAFAGE M VIENS P BAUME D CAMERLO J STOPPA AM GABUS R BRANDELY M HERCEND T MARANINCHI D
Citation: N. Vey et al., TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH HIGH-DOSE RECOMBINANT INTERLEUKIN-2 - RESULTS OF A PHASE-II STUDY IN 21 PATIENTS, Experimental hematology, 25(8), 1997, pp. 481-481
EVALUATION OF AN AMBULATORY CHEMOTHERAPY REGIME PRIOR TO AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR CHRONIC MYELOGENOUS LEUKEMIA
Authors: VEY N STOPPA AM FAUCHER C CHABANNON C BOUABDALLAH R COSTELLO R CAMERLO J LAFAGE M SAINTY M GASTAUT JA MARANINCHI D BLAISE D
Citation: N. Vey et al., EVALUATION OF AN AMBULATORY CHEMOTHERAPY REGIME PRIOR TO AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR CHRONIC MYELOGENOUS LEUKEMIA, Experimental hematology, 25(8), 1997, pp. 482-482
EARLY ALLOGENEIC TRANSPLANTATION FAVORABLY INFLUENCES THE OUTCOME OF ADULT PATIENTS SUFFERING FROM ACUTE MYELOID-LEUKEMIA
Authors: JOURDAN E MARANINCHI D REIFFERS J GLUCKMAN E RIO B JOUET JP MICHALLET M MOLINA L ARCHIMBAUD E HAROUSSEAU JL IFRAH N ATTAL M GUILHOT F KUENTZ M GUYOTAT D PICO JL DAURIAC C LEGROS M DREYFUS F BORDIGONI P LEBLOND V GRATECOS N VARET B AUZANNEAU C TILLY H VILMER E BARDOU VJ BLAISE D
Citation: E. Jourdan et al., EARLY ALLOGENEIC TRANSPLANTATION FAVORABLY INFLUENCES THE OUTCOME OF ADULT PATIENTS SUFFERING FROM ACUTE MYELOID-LEUKEMIA, Bone marrow transplantation, 19(9), 1997, pp. 875-881
EARLY AND FATAL IMMUNE HEMOLYSIS AFTER SO-CALLED MINOR ABO-INCOMPATIBLE PERIPHERAL-BLOOD STEM-CELL ALLOTRANSPLANTATION
Authors: OZIELTAIEB S FAUCHERBARBEY C CHABANNON C LADAIQUE P SAUX P GOUIN F GASTAUT JA MARANINCHI D BLAISE D
Citation: S. Ozieltaieb et al., EARLY AND FATAL IMMUNE HEMOLYSIS AFTER SO-CALLED MINOR ABO-INCOMPATIBLE PERIPHERAL-BLOOD STEM-CELL ALLOTRANSPLANTATION, Bone marrow transplantation, 19(11), 1997, pp. 1155-1156
INFLUENCE OF IRON PYRITES AND DICYANDIAMIDE ON NITRIFICATION AND AMMONIA VOLATILIZATION FROM AREA APPLIED TO LOESS BROWN EARTHS (LUVISOLS)
Authors: BLAISE D AMBERGER A VONTUCHER S
Citation: D. Blaise et al., INFLUENCE OF IRON PYRITES AND DICYANDIAMIDE ON NITRIFICATION AND AMMONIA VOLATILIZATION FROM AREA APPLIED TO LOESS BROWN EARTHS (LUVISOLS), Biology and fertility of soils, 24(2), 1997, pp. 179-182
EARLY ESTABLISHMENT OF CHIMERISM IN THE B-LYMPHOID AND T-LYMPHOID LINEAGES AFTER TRANSPLANTATION OF ALLOGENEIC MOBILIZED BLOOD-CELLS IN LEUKEMIC PATIENTS
Authors: CHABANNON C LAFAGE M MOZZICONACCI MJ FAUCHER C MARANINCHI D BLAISE D
Citation: C. Chabannon et al., EARLY ESTABLISHMENT OF CHIMERISM IN THE B-LYMPHOID AND T-LYMPHOID LINEAGES AFTER TRANSPLANTATION OF ALLOGENEIC MOBILIZED BLOOD-CELLS IN LEUKEMIC PATIENTS, Transplantation, 63(11), 1997, pp. 1646-1652
INTENSIVE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION IN OVARIAN-CANCER - ANALYSIS OF 67 PATIENTS TREATED AT THE INSTITUT-PAOLI-CALMETTES AND REVIEW OF THE LITERATURE
Authors: VIENS P BERTUCCI F GRAVIS G CAMERLO J COWEN D DELPERO JR CONTE M JACQUEMIER J FAUCHER C BLAISE D BARDOU VJ CHABANNON C BLANC AP JAUBERT D MARANINCHI D
Citation: P. Viens et al., INTENSIVE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION IN OVARIAN-CANCER - ANALYSIS OF 67 PATIENTS TREATED AT THE INSTITUT-PAOLI-CALMETTES AND REVIEW OF THE LITERATURE, Bulletin du cancer, 84(9), 1997, pp. 869-876
KARYOTYPE IN ACUTE MYELOBLASTIC-LEUKEMIA - PROGNOSTIC-SIGNIFICANCE FOR BONE-MARROW TRANSPLANTATION IN FIRST REMISSION - A EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION STUDY
Authors: FERRANT A LABOPIN M FRASSONI F PRENTICE HG CAHN JY BLAISE D REIFFERS J VISANI G SANZ MA BOOGAERTS MA LOWENBERG B GORIN NC
Citation: A. Ferrant et al., KARYOTYPE IN ACUTE MYELOBLASTIC-LEUKEMIA - PROGNOSTIC-SIGNIFICANCE FOR BONE-MARROW TRANSPLANTATION IN FIRST REMISSION - A EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION STUDY, Blood, 90(8), 1997, pp. 2931-2938
RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 130 PATIENTS WITH ACUTE-LEUKEMIA (AL) IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP
Authors: BLAISE D ATTAL M REIFFERS J STOPPA AM HUGUET F MARIT G MOLINA L BELLANGER C PICO JL GABUS R BRANDELY M HERCEND T MARANINCHI D
Citation: D. Blaise et al., RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 130 PATIENTS WITH ACUTE-LEUKEMIA (AL) IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP, Blood, 90(10), 1997, pp. 491-491
ALLOGENEIC STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - A REPORT OF THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE (SFGM)
Authors: MARIT G FACON T JOUET JP KUENTZ M VERNANT JP ARCHIMBAUD E MICHALLET M HAROUSSEAU JL MILPIED N MOLINA L SOTTO JJ GUILHOT B BLAISE D ATTAL M FABERES C TANGUY ML REIFFERS J
Citation: G. Marit et al., ALLOGENEIC STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - A REPORT OF THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE (SFGM), Blood, 90(10), 1997, pp. 996-996
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR REFRACTORY AND RECURRENT FOLLICULAR LYMPHOMA - A CASE-MATCHED ANALYSIS WITH AUTOLOGOUS TRANSPLANTATION FROM THE FRENCH BONE-MARROW TRANSPLANT GROUP REGISTRY DATA
Authors: ATTAL M SOCIE G MOLINA L JOUET JP PICO J KUENTZ M BLAISE D MILPIED N IFRAH N PAYEN C TANGUY ML
Citation: M. Attal et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR REFRACTORY AND RECURRENT FOLLICULAR LYMPHOMA - A CASE-MATCHED ANALYSIS WITH AUTOLOGOUS TRANSPLANTATION FROM THE FRENCH BONE-MARROW TRANSPLANT GROUP REGISTRY DATA, Blood, 90(10), 1997, pp. 1120-1120
PROGNOSIS VALUE OF RESIDUAL DISEASE MONITORING BY POLYMERASE CHAIN-REACTION IN PATIENTS WITH CBF-BETA MYH11-POSITIVE ACUTE MYELOBLASTIC-LEUKEMIA/
Authors: COSTELLO R SAINTY D BLAISE D GASTAUT JA GABERT J POIREL H BUZYNVEIL A MACINTYRE E
Citation: R. Costello et al., PROGNOSIS VALUE OF RESIDUAL DISEASE MONITORING BY POLYMERASE CHAIN-REACTION IN PATIENTS WITH CBF-BETA MYH11-POSITIVE ACUTE MYELOBLASTIC-LEUKEMIA/, Blood, 89(6), 1997, pp. 2222-2223
PERIPHERAL-BLOOD STEM-CELL AND BONE-MARROW TRANSPLANTATION FOR SOLID TUMORS AND LYMPHOMAS - HEMATOLOGIC RECOVERY AND COSTS - A RANDOMIZED, CONTROLLED TRIAL
Authors: HARTMANN O LECORROLLER AG BLAISE D MICHON J PHILIP I NOROL F JANVIER M PICO JL BARANZELLI MC RUBIE H COZE C PINNA A MERESSE V BENHAMOU E
Citation: O. Hartmann et al., PERIPHERAL-BLOOD STEM-CELL AND BONE-MARROW TRANSPLANTATION FOR SOLID TUMORS AND LYMPHOMAS - HEMATOLOGIC RECOVERY AND COSTS - A RANDOMIZED, CONTROLLED TRIAL, Annals of internal medicine, 126(8), 1997, pp. 600
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>